Market Highlights:

A microtome is a tool used to cut extremely thin sections of tissue samples. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. Different kinds of microtomes made up of metals and glass are used depending on the type of specimen and the desired thickness.

The growth of the global microtome market is driven by various factors such as an increase in the incidence of chronic disorders, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of skilled workforce is projected to hamper the growth of the global microtome market.

According to MRFR analysis, Microtome Market Growth is expected to register a CAGR of 6.1% during the forecast period of 2019 to 2025 and accounts for USD 120 million in 2018.

The global microtome market is currently dominated by several market players such as Danaher Corporation, Thermo Fisher Scientific, and Sakura Finetek, among others. Additionally, growing growth strategies adopted by market players are driving the growth of the market. For instance, in 2018, Sakura Finetek launched Accu-Cut SRM 300 LT, manual microtome.

Key Players:

Some of the key players in the Global Microtome Market are Amos Scientific Pty Ltd (Australia), Danaher (US), Diapath S.p.A. (Italy), Histo-Line Laboratories (Italy), Jinhua YIDI Medical Appliance Co., Ltd (China), MEDITE GmbH (Germany), Boeckeler Instruments, Inc. (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), and Thermo Fisher Scientific (US)

Segmentation

The Global Microtome Market has been segmented based on product, application, technology, and end-user.

The market, based on product, has been divided into instruments and accessories. Instruments are further sub-segmented into rotary microtomes, cryostat microtomes, vibrating microtomes, and others. Instruments are expected to hold the largest share, due to the commercial availability of these systems and their high adoption rate due to ease of handling.

In terms of application, the global microtome market has been segmented into disease diagnosis and medical research. Disease diagnosis takes up the largest share due to the increasing number of tissue examinations in research laboratories and hospitals owing to rising awareness about the benefits of early diagnosis of diseases like cancer.

In terms of technology, the global microtome market has been segmented into manual, semi-automated microtomes, and fully automated microtomes. The fully automated segment held the majority share due to rising demand for technologically advanced products and its ability to show the highest precision in section thickness. Additionally, fully automated microtomes do not require tedious manual adjustments.

In terms of end-user, the global microtome market has been segmented into hospital laboratories and clinical laboratories. Hospital laboratories take up the largest share. The positive growth of hospitals is attributed to factors such as a high volume of routine tissue examinations performed in hospital-based laboratories across the globe and growing patient population.

Regional Analysis:

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The microtome market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European microtome market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microtome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of chronic disorders and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The microtome market in the Middle East & Africa has been bifurcated into the Middle East and Africa.

Market Overview:

Adenomyosis is defined as a medical condition in which the inner lining of the uterus (also known as the endometrium) breaks through the muscle wall of the uterus (the myometrium). The treatment of this medical problem is called adenomyosis treatment. A new report on the global Adenomyosis Treatment Market Share published by Market Research Future (MRFR), states that this market can visualize progress at 4.1% CAGR during the forecast period (2018-2023). In terms of value, the market can be worth USD 291.5 Mn by the end of the forecast period.

The biggest driver for the global adenomyosis treatment market growth is the global prevalence of adenomyosis. The increasing awareness about adenomyosis as well as its treatment is boosting the global adenomyosis treatment market by creating the demand, supply, and sales for new drugs and therapies, along with advanced medical technology-focused towards the adenomyosis. Hence, new opportunities are arising for market growth. During the forecast period, increased funding for research & development (R&D) to develop more advanced products (medical devices) is expected to reflect favorably on the market. However, the market in developing countries can face hurdles as many people are not aware of this medical problem.

Key Players

• Bayer AG
• Ferring B.V
• Johnson & Johnson Consumer Inc
• Merck KGaA
• Novartis
• Pfizer Inc
• Speciality European Pharma

Market Segmentation

• The global adenomyosis treatment market segmentation encompasses diagnosis, type, and treatment. MRFR’s take on the market marks various facets of the market in-depth.
• The diagnosis-based segmentation of this market covers endometrial biopsy, magnetic resonance imaging (MRI), ultrasound, and others. The ultrasound segment has been sub-segmented into transabdominal ultrasound and endovaginal ultrasound which is also known as transvaginal ultrasound.
• By type, the market includes adenomyoma, diffuse, focal, and others.
• By treatment, the market covers anti-inflammatory drugs, hormone medications, and hysterectomy. The anti-inflammatory drugs segment has been sub-segmented into Advil, ibuprofen, Motrin ibuprofen (Motrin IB), and others.

Regional Segmentation

A geographical outlining of the global adenomyosis treatment market covers the Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA).

The Americas is the biggest regional market as North America alone has the potential of becoming a powerful regional market. Due to the advanced medical facilities being available in the USA North America is a larger regional market segment compared to South America. North America is the largest regional market segment due to the rapid adoption of new drugs and therapies. Continuous innovation on the technological front and heavy use of technology in the medical sector boost market in this region. USA and Canada are generating the maximum revenue in this region.

Europe is the second-largest regional market as many important market players are based in Europe. Due to the reasons the same as in The Americas, Western Europe is a bigger market compared to Eastern Europe. The major market share comes from France, Germany, Spain, Italy, and the UK.

The Asia Pacific region is an important regional market due to improving medical sector and stable technological progress. In this report, this regional market has been segmented into Asia and the Pacific. In Asia, the key country-specific markets are China, India, Japan, and South Korea. An observation of the remaining countries in Asia and the Pacific region featured in this report calculates the additional market revenue from some other countries.

In the MEA region, the market has been slow due to limited availability of advanced medical facilities. Countries focused in the report include Egypt, Saudi Arabia, and the UAE.

Market Potential and Pitfalls:

The primary reasons because of which people are prone to cardiovascular ailments that require CABG in order to be cured include anxiety, deskbound lifestyle, high consumption of junk food, and stress. Due to the rise in cardiovascular ailments, the market for coronary artery bypass grafting is also rising. Other factors responsible for the growth of this market include changing lifestyle, increase in patient’s awareness of this ailment, and surgeries & therapies related to CABG. 

Market Synopsis:

Market Research Future (MRFR) postulates that the global Coronary Artery Bypass Graft Market Size is slated to garner USD 116 million, grabbing a CAGR of 6.0% during the forecast period (2016-2022). The surging incidences of cardiovascular disease due to changing lifestyle is estimated to favor the market growth worldwide. Coronary artery bypass grafting (CABG) is referred to as a type of bypass surgery used to create new routes for the blood to flow into the heart. CABG is generally used in patients suffering from severe coronary heart disease. CABG is caused due to anxiety, deskbound lifestyle, high consumption of junk food, and stress. Observing the market structure, this report estimates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market. The primary reasons because of which people are prone to cardiovascular ailments that require CABG in order to be cured include anxiety, deskbound lifestyle, high consumption of junk food, and stress. Due to the rise in cardiovascular ailments, the market for coronary artery bypass grafting is also rising. Other factors responsible for the growth of this market include changing lifestyle,

increase in patient’s awareness of this ailment, and surgeries & therapies related to

CABG.

Competitive Dashboard:

• Genesee BioMedical
• MAQUET Holding B.V. & Co. KG
• Edwards Lifesciences Corporatio
• Neograft Inc
• Sorin Group
• Dextera Surgical Inc
• Terumo Cardiovascular Systems Corporation
• VasoPrep Surgical
• Hancock Jaffe Laboratories Inc
• NOVADAQ Technologies Inc

Global Coronary Artery Bypass Graft Market: Segmental Analysis:

• The global coronary artery bypass graft market has been segmented on the basis of type, procedure, and end-users.
• By mode of type, the global coronary artery bypass graft market has been segmented into on-pump, off-pump, endoscopic vein harvesting, minimally invasive direct CABG, and others. Among these, the off-pump segment is estimated to gain significant prominence in the long run due to the advantages it offers. The reduced inflammatory response, minimal blood loss, lower postoperative complications, mortality rate, and lower morbidity drive the segment globally.
• By mode of procedure, the global coronary artery bypass graft market has been segmented into double CABG surgery, single CABG surgery, quadruple CABG surgery, triple CABG surgery, and others.
• By mode of end-users, the global coronary artery bypass graft market has been segmented into cardiology clinics, hospitals, research institutes, and others.

Regional Insights:

Globally North America is leading the global coronary artery bypass graft market which is further expected to grow with approximately 6.4% CAGR during the forecast period (2016-2022). Moreover, factors such as the high per capita healthcare spending and the growing population in the region are expected to spur the market growth in the region.

Markets in the U.S. and Canada led by the rising number of bypass surgeries and the growing prevalence of coronary diseases lead the regional market. Furthermore, the rapid uptake of advanced technologies and devices in the surgical process is also an essential driver of the market.

The European region witnessing the increasing number of coronary artery bypass procedures accounts for the second-largest market, globally. Factors such as increasing healthcare expenditures and spreading awareness of CABG procedures impact the market growth in the region.  Also, the resurging economy is playing a vital role in increasing the market value in the region.

Furthermore, factors such as the availability of specialty care services in hospitals & tertiary care centers, increasing demand for the treatment options of cardiovascular diseases, and rising prevalence of cardiovascular diseases escalate the market growth in the region.

Moreover, factors positively impacting the growth of the regional market include the growing emphasis on coronary artery bypass procedures and increasing geriatric population with chronic diseases such as diabetes & obesity which increase the risk for heart disease, and rising prevalence of cardiovascular diseases.

.

Market Highlights:

 According to the World Heart Federation, 3 million people get affected with the rheumatic heart disease every year. Also, according to the Centers for Disease Control and Prevention August 2018, 370 cases of meningitis were reported in the US in 2016. Such an incidence of rheumatic heart disease and meningitis supports market growth.

Benzathine Penicillin G is an antibody used to treat various bacterial infections. It is also used in the treatment of rheumatic fever and related heart problems. The Benzathine Penicillin G Market is expected to witness tremendous growth owing to the rising prevalence of various bacterial infections such as gonorrhea, meningitis, and others. Other key factors such as a change to sedentary lifestyle, infectious diseases, respiratory infections caused due to bacterial infections, and rheumatic heart diseases contribute towards the growth of the market.

However, factors such as lack of awareness about the treatment and the side effects associated with treatments are expected to hinder the growth of the Benzathine Penicillin G market during the forecast period.

Key Players:

• Abcam plc
• Pfizer Inc
• Alembic IT Department
• ECPlaza Network Inc
• Sandoz International GmbH
• Merck KGaA
• Triveni Interchem Private Limited
• CSC Pharmaceuticals

Segmentation:

• The global Benzathine Penicillin G market is segmented on the basis of application, mode of injection, and end user.
• The Benzathine Penicillin G market, by application, is segmented into bacterial infections and sexually transmitted infection (STI) syphilis therapy. Bacterial infections are further segmented into Bejel, diphtheria, and rheumatic fever.
• On the basis of mode of injection, the market is segmented into intravenous and intramuscular injection.
• On the basis of end user, the global Benzathine Penicillin G market is segmented into hospitals and clinics, diagnostic centers, ambulatory surgical centers, research centers, and others.

Regional Analysis:

The Americas is the largest in the market owing to the increasing prevalence of rheumatic heart disorders and growing healthcare expenditure. According to the National Meningitis Association December 2014, every year approximately 600 to 1000 people are affected by the meningococcal disease in the US. Such a high incidence rate of meningococcal disease drives the market growth in this region.

Europe (UK, Belgium, France, and Netherlands) is expected to be the second largest Benzathine Penicillin G market during the forecast period. The increasing occurrence of sexually infective diseases positively drives the market in this region. According to the European Centre for Disease Prevention and Control, September 2015, it is estimated that every year approximately 146 million cases of sexually transmitted infections are found worldwide. In Europe, 385 000 cases were reported in 2013 which may increase during the forecast period. Thus, the growing cases of sexually transmitted infections facilitate market growth.

Asia-Pacific was projected to be the fastest growing region for the global Benzathine Penicillin G market in 2017. The market is expected to witness growth owing to the increasing awareness about the treatment and increasing research and development centers in this region.

Market Overview:

Prefilled syringes are defined as disposable syringes (meant for one-time use) that are alreadyfilled with the pharmaceutical substances that are to be injected into the patient’s body. A new report on the global prefilled syringes market, published by Market Research Future (MRFR),points out that this market could see a rise at 10.20% CAGR between 2016 and 2024. In terms ofmoney value, the market can be worth USD 8397.23 Mn by the end of the forecast period.

A new report on the global Prefilled Syringes Market published by Market Research Future (MRFR), points out that this market could see a rise at 10.20% CAGR between 2016 and 2024. In terms of money value, the market can be worth USD 8397.23 Mn by the end of the forecast period.

Key Players:

• Abbott
• Baxter International
• Becton Dickinson & Company
• Gerresheimer AG
• Medtronic
• Nipro Corporation
• OMPI
• Schott AG
• Terumo Corporation
• Vetter Pharma International GmbH
• Weigao Group
• West Pharmaceutical

Market Segmentation:

• The global prefilled syringes market segmentation encompasses design, end-user, material, and type. MRFR’s take on the market surveys various facets of the market in-depth.
• The design-based segmentation of this market covers single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. During the forecast period, the dual-chamber prefilled syringes segment is expected to grow at 10.31% CAGR. Single-chamber prefilled syringes segment is expected to hold the larger market share of 56% in the global market.
• Regarding end-users, the market has been segmented into the ambulatory surgical center and hospitals/clinics. Due to the growing number of public hospitals as well as private hospitals, the hospitals segment has been anticipated to grow faster during the forecast period.
• Based on material, the market has been segmented into glass prefilled syringes and plastic syringes. The glass prefilled syringes segment has been sub-segmented into baked on silicone syringes and oil siliconized syringes. Plastic syringes segment has higher growth due to its usage in many applications of pharmaceutical packaging during the forecast period.
• By type, the market has been segmented into conventional prefilled syringes and safety prefilled syringes. Conventional prefilled syringes held the larger market share of about 68% in 2017.

Regional Segmentation:

The regional analysis of the prefilled syringes market globally consists of regions is divided into Europe, Americas, Asia Pacific, Middle East and Africa.

The European region is responsible for the leading market share of about 41.4 percent in the year 2017 and is expected to lead the prefilled syringes market globally. The higher share is majorly attributed to the rising geriatric population, demand for quality healthcare and growing trend of home-based treatment separate with high healthcare expenditure.

The Americas region is responsible for the second biggest market portion, whereas the Asia Pacific region is anticipated to develop at a rapid expansion rate of about 10.78 percent during the forecast period. With loads of prospects and unceasingly developing economies, the region is expected to be among the rapidly growing area. Moreover, factors such as Japan’s quick adoption of plastic devices along with the modern healthcare developments, and increasing number of private and public hospitals, are promoting the growth of the market.

The Middle East and Africa region with a lesser degree of economic developments and very low-income per capita is responsible for the minimum market share in 2017 but is likely to develop in the future.

Latest Industry News

• Made by Regeneron, chemistry, manufacturing, and controls prior-approval supplement for the Eylea injection prefilled syringe that has been approved by the USFDA. 13 AUG 2019